{"product_id":"synthetic-biology-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","title":"Synthetic Biology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028","description":"\u003cp\u003eSynthetic Biology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028\u003cbr\u003e\nMarket Overview:\u003c\/p\u003e\n\n\u003cp\u003eThe global synthetic biology market size reached US$ 13.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 38.8 Billion by 2028, exhibiting a growth rate (CAGR) of 18.1% during 2023-2028.\u003c\/p\u003e\n\n\u003cp\u003eSynthetic biology refers to a field of research involving the construction and designing of new biological entities, such as enzymes, genetic circuits, and cells or redesigning organisms for valuable purposes by engineering them to have unique abilities. It combines the chemical synthesis of deoxyribonucleic acid (DNA) with genomics to enable researchers to manufacture cataloged DNA sequences and assemble them into new genomes. It assists in improving the environment by discovering novel ways to reduce pollution, making industrial processes for chemical synthesis sustainable, and removing the need for damaging farming practices by making better fertilizers.\u003c\/p\u003e\n\n\u003cp\u003eSynthetic Biology Market Trends:\u003cbr\u003e\nIn recent years, improvements in the speed and cost of DNA synthesis have enabled scientists in designing and synthesizing modified bacterial chromosomes, which can be utilized in the production of advanced biofuels, bio-products, renewable chemicals, and bio-based specialty chemicals. This, in confluence with increasing investments in synthetic biology, represents one of the key factors impelling the growth of the market. Moreover, synthetic biology is employed in the healthcare sector as it can help improve diagnosis and develop better treatment options for numerous diseases, directed only towards the site of disease without causing any adverse effects. Besides this, there is a significant rise in the use of genetically engineered viruses to correct defective genes in patients with inherited diseases like epidermolysis bullosa or severe combined immune deficiency (SCID). Apart from this, tools for performing synthetic biology are becoming more accessible, and the internet penetration has enabled ideas and information to be freely exchanged, which is facilitating the market growth. Furthermore, significant growth in the healthcare sector and the rising number of synthetic biology research entities worldwide are positively influencing the market.\u003c\/p\u003e\n\n\u003cp\u003eKey Market Segmentation:\u003cbr\u003e\nIMARC Group provides an analysis of the key trends in each sub-segment of the global synthetic biology market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, technology and application.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Product:\u003c\/p\u003e\n\n\n\u003cp\u003eOligonucleotide\/Oligo Pools and Synthetic DNA\u003cbr\u003e\nEnzymes\u003cbr\u003e\nCloning Technologies Kits\u003cbr\u003e\nXeno-nucleic Acids\u003cbr\u003e\nChassis Organism\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Technology:\u003c\/p\u003e\n\n\u003cp\u003eNGS Technology\u003cbr\u003e\nPCR Technology\u003cbr\u003e\nGenome Editing Technology\u003cbr\u003e\nBioprocessing Technology\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Application:\u003c\/p\u003e\n\n\u003cp\u003eHealthcare\u003cbr\u003e\nClinical\u003cbr\u003e\nNon-Clinical\/Research\u003cbr\u003e\nNon-Healthcare\u003cbr\u003e\nBiotech Crops\u003cbr\u003e\nSpecialty Chemicals\u003cbr\u003e\nBio-Fuels\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Region:\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003cbr\u003e\nUnited States\u003cbr\u003e\nCanada\u003cbr\u003e\nAsia-Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nIndia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nAustralia\u003cbr\u003e\nIndonesia\u003cbr\u003e\nOthers\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nUnited Kingdom\u003cbr\u003e\nItaly\u003cbr\u003e\nSpain\u003cbr\u003e\nRussia\u003cbr\u003e\nOthers\u003cbr\u003e\nLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003cbr\u003e\nOthers\u003cbr\u003e\nMiddle East and Africa\u003cbr\u003e\n \u003cbr\u003e\nCompetitive Landscape:\u003cbr\u003e\nThe competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Amyris Inc., Codexis Inc., Danaher Corporation, Eurofins Scientific, GenScript Biotech Corporation, Illumina Inc., Merck KGaA, New England Biolabs, Synthego Corporation, Thermo Fisher Scientific Inc., Twist Bioscience and Viridos Inc.\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Answered in This Report:\u003cbr\u003e\nHow has the global synthetic biology market performed so far and how will it perform in the coming years?\u003cbr\u003e\nWhat has been the impact of COVID-19 on the global synthetic biology market?\u003cbr\u003e\nWhat are the key regional markets?\u003cbr\u003e\nWhat is the breakup of the market based on the product?\u003cbr\u003e\nWhat is the breakup of the market based on the technology?\u003cbr\u003e\nWhat is the breakup of the market based on the application?\u003cbr\u003e\nWhat are the various stages in the value chain of the industry?\u003cbr\u003e\nWhat are the key driving factors and challenges in the industry?\u003cbr\u003e\nWhat is the structure of the global synthetic biology market and who are the key players?\u003cbr\u003e\nWhat is the degree of competition in the industry?\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"July, 2023 \/ 141 Pages \/ MCW16231074","offer_id":47647260836146,"sku":null,"price":2999.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/synthetic-biology-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}